These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7562758)

  • 1. Is it possible to reduce observer variability in skin score assessment of scleroderma? The ad hoc International Group on the Assessment of Disease Outcome in Scleroderma.
    Silman A; Harrison M; Brennan P
    J Rheumatol; 1995 Jul; 22(7):1277-80. PubMed ID: 7562758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
    Clements P; Lachenbruch P; Siebold J; White B; Weiner S; Martin R; Weinstein A; Weisman M; Mayes M; Collier D
    J Rheumatol; 1995 Jul; 22(7):1281-5. PubMed ID: 7562759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of skin scores and clinical measurements in scleroderma.
    Pope JE; Baron M; Bellamy N; Campbell J; Carette S; Chalmers I; Dales P; Hanly J; Kaminska EA; Lee P
    J Rheumatol; 1995 Jul; 22(7):1271-6. PubMed ID: 7562757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.
    Clements PJ; Lachenbruch PA; Seibold JR; Zee B; Steen VD; Brennan P; Silman AJ; Allegar N; Varga J; Massa M
    J Rheumatol; 1993 Nov; 20(11):1892-6. PubMed ID: 8308774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
    Shand L; Lunt M; Nihtyanova S; Hoseini M; Silman A; Black CM; Denton CP
    Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
    Furst DE; Clements PJ; Steen VD; Medsger TA; Masi AT; D'Angelo WA; Lachenbruch PA; Grau RG; Seibold JR
    J Rheumatol; 1998 Jan; 25(1):84-8. PubMed ID: 9458208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of relationship between functional ability and skin score in patients with systemic sclerosis.
    Herrick A; Rooney B; Finn J; Silman A
    J Rheumatol; 2001 Feb; 28(2):292-5. PubMed ID: 11246664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
    Sultan N; Pope JE; Clements PJ;
    Rheumatology (Oxford); 2004 Apr; 43(4):472-8. PubMed ID: 14679295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome measurements in scleroderma: results from a delphi exercise.
    Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
    J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized scleroderma severity index and global assessments: a pilot study of outcome instruments.
    Arkachaisri T; Pino S
    J Rheumatol; 2008 Apr; 35(4):650-7. PubMed ID: 18322985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis.
    Moore TL; Lunt M; McManus B; Anderson ME; Herrick AL
    Rheumatology (Oxford); 2003 Dec; 42(12):1559-63. PubMed ID: 12867579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and partial validation of a patient skin self-assessment questionnaire in systemic sclerosis.
    Nagy Z; Bálint Z; Farkas H; Radics J; Kumánovics G; Minier T; Varjú C; Czirják L
    Rheumatology (Oxford); 2009 Mar; 48(3):309-14. PubMed ID: 19181657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and Intra-Observer Reliability of Modified Rodnan Skin Score Assessment in Thai Systemic Sclerosis Patients: A Validation for Multicenter Scleroderma Cohort Study.
    Foocharoen C; Thinkhamrop B; Mahakkanukrauh A; Suwannaroj S; Netwijitpan S; Sripavatakul K; Chuealee W; Boottam B; Towiwat P; Seubmee P; Daungkum K; Kongpan D; Mangkala J; Nanagara R
    J Med Assoc Thai; 2015 Nov; 98(11):1082-8. PubMed ID: 26817178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
    Clements PJ; Hurwitz EL; Wong WK; Seibold JR; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen VD; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Furst DE
    Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis.
    Czirják L; Nagy Z; Aringer M; Riemekasten G; Matucci-Cerinic M; Furst DE;
    Ann Rheum Dis; 2007 Jul; 66(7):966-9. PubMed ID: 17234649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of hardness, elasticity and viscosity of the skin of patients with systemic sclerosis using a novel sensing device (Vesmeter): a proposal for a new outcome measurement procedure.
    Kuwahara Y; Shima Y; Shirayama D; Kawai M; Hagihara K; Hirano T; Arimitsu J; Ogata A; Tanaka T; Kawase I
    Rheumatology (Oxford); 2008 Jul; 47(7):1018-24. PubMed ID: 18440998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.